当前位置:首页 - 行情中心 - 华兰生物(002007) - 财务分析 - 现金流量表

华兰生物

(002007)

  

流通市值:253.84亿  总市值:294.77亿
流通股本:15.74亿   总股本:18.27亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,056,450,334.042,017,751,654.45837,034,153.634,934,564,892.16
  收到的税费返还---10,763,868.93
  收到其他与经营活动有关的现金49,577,991.2231,682,074.4315,047,349.6968,051,640.95
  经营活动现金流入小计3,106,028,325.262,049,433,728.88852,081,503.325,013,380,402.04
  购买商品、接受劳务支付的现金1,201,832,710.1850,392,734.93416,525,887.581,655,884,984.83
  支付给职工以及为职工支付的现金376,796,113.02259,013,142.67144,793,794.69478,493,657.33
  支付的各项税费295,882,306.07196,142,364.4596,652,099.95505,016,300.05
  支付其他与经营活动有关的现金780,888,381.48513,378,528.05179,931,139.391,314,640,297.95
  经营活动现金流出小计2,655,399,510.671,818,926,770.1837,902,921.613,954,035,240.16
  经营活动产生的现金流量净额450,628,814.59230,506,958.7814,178,581.711,059,345,161.88
二、投资活动产生的现金流量:
  收回投资收到的现金9,476,763,328.537,405,875,686.754,251,514,785.5123,636,287,582.53
  取得投资收益收到的现金195,988,242.7196,651,869.8971,006,687.85135,294,495.93
  处置固定资产、无形资产和其他长期资产收回的现金净额480,068.6542,79225,712892,593.2
  处置子公司及其他营业单位收到的现金净额---1,550,000
  投资活动现金流入小计9,673,231,639.897,502,570,348.644,322,547,185.3623,774,024,671.66
  购建固定资产、无形资产和其他长期资产支付的现金148,340,438.42112,188,844.6867,866,067.66255,428,449.3
  投资支付的现金8,788,517,908.46,882,517,908.44,611,335,357.2623,428,157,926.61
  支付其他与投资活动有关的现金-12,84012,840362,323.91
  投资活动现金流出小计8,936,858,346.826,994,719,593.084,679,214,264.9223,683,948,699.82
  投资活动产生的现金流量净额736,373,293.07507,850,755.56-356,667,079.5690,075,971.84
三、筹资活动产生的现金流量:
  吸收投资收到的现金---16,281,000
  取得借款收到的现金724,405,900.01278,159,999.98278,704,844.44596,468,571.01
  筹资活动现金流入小计724,405,900.01278,159,999.98278,704,844.44612,749,571.01
  偿还债务支付的现金1,179,380,000819,380,000100,000,000700,000,000
  分配股利、利润或偿付利息支付的现金390,198,653.05386,700,910.797,612,869.43585,446,171.58
  其中:子公司支付给少数股东的股利、利润56,360,006.656,360,006.6-117,616,500
  支付其他与筹资活动有关的现金14,023,913.414,023,913.4-107,736,520.27
  筹资活动现金流出小计1,583,602,566.451,220,104,824.1197,612,869.431,393,182,691.85
  筹资活动产生的现金流量净额-859,196,666.44-941,944,824.1281,091,975.01-780,433,120.84
四、汇率变动对现金及现金等价物的影响175,338.16189,692.0175,438.63-52,406.71
五、现金及现金等价物净增加额327,980,779.38-203,397,417.77-261,321,084.21368,935,606.17
  加:期初现金及现金等价物余额1,358,260,221.681,358,260,221.681,358,260,221.68989,324,615.51
  期末现金及现金等价物余额1,686,241,001.061,154,862,803.911,096,939,137.471,358,260,221.68
补充资料:
  净利润-522,691,390.04-1,155,469,792.25
  资产减值准备--12,277,453.7-74,225,065.72
  固定资产和投资性房地产折旧-130,752,182.59-248,723,026.77
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-130,752,182.59-248,723,026.77
  无形资产摊销-6,096,426.39-11,732,164.68
  长期待摊费用摊销-2,944,181.02-11,314,041.8
  处置固定资产、无形资产和其他长期资产的损失-21,450.45--78,661.39
  固定资产报废损失-1,464,932.24-5,709,620.93
  公允价值变动损失--12,504,878.82--32,940,014.29
  财务费用-4,560,270.78-13,124,519.99
  投资损失--78,427,996.02--137,517,910.98
  递延所得税--8,544,518.86-3,707,251.35
  其中:递延所得税资产减少--8,608,932.01-6,385,601.46
    递延所得税负债增加-64,413.15--2,678,350.11
  存货的减少--262,647,350.4--416,884,677.76
  经营性应收项目的减少-378,167,420.25-840,461,407.42
  经营性应付项目的增加--413,062,669.54--723,825,743.11
  其他-5,527,310.88-11,084,642.93
  现金的期末余额-1,154,862,803.91-1,358,260,221.68
  减:现金的期初余额-1,358,260,221.68-989,324,615.51
  现金及现金等价物的净增加额--203,397,417.77-368,935,606.17
公告日期2025-10-302025-08-282025-04-282025-03-29
审计意见(境内)标准无保留意见
TOP↑